Letrozole 25 Hilma Biocare

£36.00

Letrozole 25 Hilma Biocare is a third-generation aromatase inhibitor research compound manufactured for in-vitro laboratory studies investigating estrogen suppression mechanisms and hormonal pathway modulation in controlled research environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Letrozole 25 Hilma Biocare
Letrozole 25 Hilma Biocare
£36.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: Letrozole 25 Hilma Biocare

Letrozole 25 Hilma Biocare is a third-generation aromatase inhibitor research compound designed for in-vitro laboratory investigations. This potent non-steroidal compound blocks the aromatase enzyme, which converts androgens to estrogens, making it valuable for researchers studying hormonal pathway modulation. As a leading Stroid UK Shop, we provide this compound exclusively for laboratory research applications. Letrozole demonstrates superior binding affinity to the aromatase enzyme compared to earlier generation inhibitors, offering researchers precise tools for examining estrogen suppression mechanisms in controlled experimental settings.

Laboratory Research Applications

Researchers examine Letrozole 25 for its ability to inhibit estrogen biosynthesis at the cellular level. Studies investigate its mechanism of blocking the final step in estrogen production, where androgens are converted to estradiol and estrone. This compound enables researchers to analyse hormonal feedback loops and evaluate estrogen-dependent cellular processes. Scientists also study its effects on various tissue types and its selectivity for different aromatase enzyme isoforms. The compound’s reversible binding characteristics make it particularly useful for temporal studies examining estrogen recovery patterns. Researchers studying aromatase inhibition mechanisms often compare its efficacy against other research compounds available through specialised suppliers offering SARMs and peptides for comprehensive hormonal research protocols.

Technical Specifications

Letrozole 25 Hilma Biocare Research Specifications
Parameter Specification
Active Compound Letrozole
Concentration 2.5mg per tablet
Manufacturer Hilma Biocare
Form Oral tablets
CAS Number 112809-51-5
Molecular Formula C17H11N5
Storage Room temperature, dry conditions
Research Grade Laboratory standard

Research Compliance Statement

Letrozole 25 Hilma Biocare is manufactured exclusively for in-vitro research and laboratory analysis. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must comply with all applicable regulations governing research chemical handling and disposal. All studies should be conducted by qualified personnel in appropriately equipped laboratory facilities with proper safety protocols.

Related